December 19, 2014 5:10 PM ET


Company Overview of Grupo Roche Syntex de México, S.A. de C.V.

Company Overview

Grupo Roche Syntex de México, S.A. de C.V. manufactures and markets pharmaceutical and diagnostic products. The company develops drugs for the prevention and treatment of cancer, metabolic disorders, and cardiovascular infectious, dermatologic, inflammatory, and autoimmune diseases. Additionally, it produces diagnostic tests and systems. It markets its products under Avastin, Valium, Neotigason, Valcyte, Madopar, Rocaltrol, CellCept, and Accu-Chek brand names. The company is based in Mexico City, Mexico. Grupo Roche Syntex de México, S.A. de C.V. is a subsidiary of Roche Holding AG.

Cerrada de Bezares No. 9

Col. Lomas de Bezares

México, DF 11910


Founded in 1944


52 55 5258 5000


52 55 5258 5472

Key Executives for Grupo Roche Syntex de México, S.A. de C.V.

General Director
Compensation as of Fiscal Year 2014.

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Grupo Roche Syntex de México, S.A. de C.V., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at